Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Vaccines

  2.3.2 Market Size By Antiviral Therapeutics

  2.3.3 Market Size By Supportive Care Drugs

  2.3.4 Market Size By Distribution Channel

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

  4.1 Adoption & Utilization Metrics

4.1.1 Patient population receiving vaccination in endemic regions

4.1.2 Prescription and usage trends across supportive care categories

4.1.3 Therapy adherence and completion rates (%) for vaccination schedules

4.1.4 Adoption of combination supportive care versus single‑drug therapy

4.1.5 Growth rate (%) in home‑based vaccination versus hospital‑based administration

    4.2 Clinical Outcome & Safety Metrics

4.2.1 Vaccine‑induced immunity success rates (%) in target populations

4.2.2 Reduction in outbreak incidence following mass campaigns

4.2.3 Incidence of adverse reactions and post‑vaccination complications

4.2.4 Hospital readmission rates (%) linked to Yellow Fever treatment outcomes

4.2.5 Patient‑reported improvements in recovery and quality of life

    4.3 Technology & Innovation Metrics

4.3.1 Share (%) of recombinant and thermostable vaccines in development pipelines

4.3.2 Number of active clinical trials for novel antivirals and vaccine candidates

4.3.3 Growth (%) in adoption of AI‑based outbreak prediction and digital tracking tools

4.3.4 Investment trends in vaccine R&D by leading pharmaceutical companies

4.3.5 Introduction of new formulations (single‑dose, thermostable, extended‑release)

    4.4 Regulatory & Reimbursement Metrics

4.4.1 Number of vaccines and therapeutics approved by major regulatory bodies (WHO, FDA, EMA, etc.)

4.4.2 Average approval timelines for new vaccine candidates

4.4.3 Reimbursement coverage across public health systems and private insurers

4.4.4 Frequency of label updates and post‑market safety monitoring studies

4.4.5 Government procurement policies and international supply agreements

5. Yellow Fever Treatment Market Segmental Analysis & Forecast, By Vaccines, 2022 – 2035, Value (USD Million)

5.1 Introduction

 5.2 Live-attenuated vaccines

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

 5.3 Recombinant vaccines

 5.4 Inactivated vaccines

     5.5 Antiviral therapeutics

     5.6 Others

6. Yellow Fever Treatment Market Segmental Analysis & Forecast, By Antiviral Therapeutics, 2022 – 2035, Value (USD Million)

    6.1 Introduction

 6.2 Experimental antivirals

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

     6.3 Combination therapies

     6.4 Combination therapies

     6.5 Others

7. Yellow Fever Treatment Market Segmental Analysis & Forecast, By Supportive Care Drugs, 2022 – 2035, Value (USD Million)

    7.1 Introduction

 7.2 Antipyretics (fever management)

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

 7.3 Proton Pump Inhibitors (GI protection)

     7.4 Histamine H2 antagonists

     7.5 Others

8. Yellow Fever Treatment Market Segmental Analysis & Forecast, By Distribution Channel, 2022 – 2035, Value (USD Million)

    8.1 Introduction

 8.2 Government Procurement Agencies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022 – 2035

     8.3 Hospital Pharmacies

     8.4 Retail & Online Pharmacies

     8.5 Others

9. Yellow Fever Treatment Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Million)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Yellow Fever Treatment Market Size & Forecast, By Vaccines, 2022 – 2035

 9.2.3 Yellow Fever Treatment Market Size & Forecast, By Antiviral Therapeutics, 2022 – 2035

 9.2.4 Yellow Fever Treatment Market Size & Forecast, By Supportive Care Drugs, 2022 – 2035

 9.2.5 Yellow Fever Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.2.6 Yellow Fever Treatment Market Size & Forecast, By Country, 2022 – 2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Yellow Fever Treatment Market Size & Forecast, By Vaccines, 2022 – 2035

 9.3.3 Yellow Fever Treatment Market Size & Forecast, By Antiviral Therapeutics, 2022 – 2035

 9.3.4 Yellow Fever Treatment Market Size & Forecast, By Supportive Care Drugs, 2022 – 2035

 9.3.5 Yellow Fever Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.3.6 Yellow Fever Treatment Market Size & Forecast, By Country, 2022 – 2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Yellow Fever Treatment Market Size & Forecast, By Vaccines, 2022 – 2035

 9.4.3 Yellow Fever Treatment Market Size & Forecast, By Antiviral Therapeutics, 2022 – 2035

 9.4.4 Yellow Fever Treatment Market Size & Forecast, By Supportive Care Drugs, 2022 – 2035

 9.4.5 Yellow Fever Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.4.6 Yellow Fever Treatment Market Size & Forecast, By Country, 2022 – 2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Yellow Fever Treatment Market Size & Forecast, By Vaccines, 2022 – 2035

 9.5.3 Yellow Fever Treatment Market Size & Forecast, By Antiviral Therapeutics, 2022 – 2035

 9.5.4 Yellow Fever Treatment Market Size & Forecast, By Supportive Care Drugs, 2022 – 2035

 9.5.5 Yellow Fever Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.5.6 Yellow Fever Treatment Market Size & Forecast, By Country, 2022 – 2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Yellow Fever Treatment Market Size & Forecast, By Vaccines, 2022 – 2035

 9.6.3 Yellow Fever Treatment Market Size & Forecast, By Antiviral Therapeutics, 2022 – 2035

 9.6.4 Yellow Fever Treatment Market Size & Forecast, By Supportive Care Drugs, 2022 – 2035

 9.6.5 Yellow Fever Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.6.6 Yellow Fever Treatment Market Size & Forecast, By Country, 2022 – 2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022 – 2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Network Type Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Network Type Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

  10.6.1 Sanofi Pasteur SA

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

10.6.2 Bio-Manguinhos (Fiocruz, Brazil)

10.6.3 GlaxoSmithKline plc (GSK)

10.6.4 Pfizer Inc.

10.6.5 Johnson & Johnson Services, Inc. (Janssen)

10.6.6 Takeda Pharmaceutical Company Ltd.

10.6.7 Bayer AG

 10.6.8 BioCryst Pharmaceuticals, Inc.

10.6.9 Tychan Pte. Ltd.

10.6.10 Emergent BioSolutions Inc.

10.6.11 Novartis AG

10.6.12 Merck & Co., Inc.

10.6.13 AbbVie Inc.

10.6.14 CSL Limited (Seqirus)

10.6.15 Moderna, Inc.

10.6.16 AstraZeneca plc

10.6.17 Roche Holding AG

 10.6.18 Serum Institute of India

10.6.19 Indian Immunologicals Ltd.

10.6.20 Panacea Biotec Ltd.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List of Tables

 14.2 List of Figures